Fellowship · Columbus, OH
Sponsored by Ohio State University Hospital
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
The New England journal of medicine · 2023 · 451 citations · Carlos Malvestutto
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
American journal of respiratory and critical care medicine · 2025 · 112 citations · Shu-Hua Wang
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
JAMA cardiology · 2024 · 89 citations · Carlos Malvestutto
Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019.
JAMA network open · 2023 · 79 citations · Susan Koletar
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE.
The lancet. HIV · 2025 · 30 citations · Carlos Malvestutto
Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
JAMA · 2023 · 63 citations ·
Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 36 citations · Susan Koletar
Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026 · 10 citations · Carlos Malvestutto